Filter
1191
Text search:
human
pharmaceutical
products
Featured
116
322
Language
Document type
554
260
191
72
70
15
14
8
4
2
1
Countries / Regions
59
51
38
36
28
27
26
26
24
22
20
18
18
17
16
15
15
14
13
12
12
12
12
11
11
9
9
8
7
6
6
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
488
84
62
57
32
23
9
1
Toolboxes
159
129
72
56
46
38
36
35
26
22
22
20
19
19
17
14
13
8
7
6
5
5
3
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us
...
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
NHSP 2017- 2022 (Final draft)
Stop TB Communicable Diseases
Guidance on Implending Publi-Private Mix Approaches
